Disclosed herein are novel pharmaceutical cocrystals of temozolomide using co-crystal coformers selected from aliphatic and aromatic carboxylic acids in fixed stoichiometric ratio. The novel Temozolomide-carboxylic acid cocrystals exhibit improved hydrolytic stability and good aqueous dissolution rate compared to the pure drug.
展开▼